The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-β-arrestin complexes after receptor endocytosis
Open accessAbstract
beta-Arrestins bind agonist-activated G protein-coupled receptors (GPCRs) and mediate their desensitization and internalization. Although beta-arrestins dissociate from some receptors at the plasma membrane, such as the beta2 adrenergic receptor, they remain associated with other GPCRs and internalize with them into endocytic vesicles. Formation of stable receptor-beta-arrestin complexes that persist inside the cell impedes receptor resensitization, and the aberrant formation of these complexes may play a role in GPCR-based diseases (Barak, L. S., Oakley, R. H., Laporte, S. A., and Caron, M. G. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 93-98). Here, we investigate the molecular determinants responsible for sustained receptor/beta-arrestin interactions. We show in real time and in live human embryonic kidney (HEK-293) cells that a beta-arrestin-2-green fluorescent protein conjugate internalizes into endocytic vesicles with agonist-activated neurotensin-1 receptor, oxytocin receptor, angiotensin II type 1A receptor, and substance P receptor. Using receptor mutagenesis, we demonstrate that the ability of beta-arrestin to remain associated with these receptors is mediated by specific clusters of serine and threonine residues located in the receptor carboxyl-terminal tail. These clusters are remarkably conserved in their position within the carboxyl-terminal domain and serve as primary sites of agonist-dependent receptor phosphorylation. In addition, we identify a beta-arrestin mutant with enhanced affinity for the agonist-activated beta2-adrenergic receptor that traffics into endocytic vesicles with receptors that lack serine/threonine clusters and normally dissociate from wild-type beta-arrestin at the plasma membrane. By identifying receptor and beta-arrestin residues critical for the formation of stable receptor-beta-arrestin complexes, these studies provide novel targets for regulating GPCR responsiveness and treating diseases resulting from abnormal GPCR/beta-arrestin interactions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, (Vargas-Pinilla et al., 2015) identified a new phosphorylation site in the OTR of Callithrix at R149S, and the shortening of a Ser cluster in the OTR of Saguinus that is important for β-arrestin mediated desensitization and receptor recycling (Innamorati et al., 1998; Oakley et al., 2001; Vargas-Pinilla et al., 2015).”
From Neuropeptide diversity and the regulation of social behavior in New World primates (2016) · cites this paper as Oakley et al., 2001
Citations
Cites
β-Arrestin-Dependent Formation of β 2 Adrenergic Receptor-Src Protein Kinase Complexes
Luttrell, L. M., Ferguson, S. S. G., Daaka, Y., Miller, W. E., Maudsley, S. R., Rocca, G. J. D., Lin, F., Kawakatsu, H., Owada, K. M., Luttrell, D. K., et al. (1999) · Science · doi:10.1126/science.283.5402.655 · Cited by 1,473
β-Arrestin acts as a clathrin adaptor in endocytosis of the β2-adrenergic receptor
Goodman, O. B., Krupnick, J. G., Santini, F., Gurevich, V. V., Penn, R. B., Gagnon, A. W., Keen, J. H., & Benovic, J. (1996) · Nature · doi:10.1038/383447a0 · Cited by 1,383
β-Arrestin: a Protein that Regulates β-adrenergic Receptor Function
Lohse, M. J., Benovic, J., Codina, J., Caron, M. G., & Lefkowitz, R. J. (1990) · Science · doi:10.1126/science.2163110 · Cited by 1,222
THE ROLE OF RECEPTOR KINASES AND ARRESTINS IN G PROTEIN–COUPLED RECEPTOR REGULATION
Krupnick, J. G., & Benovic, J. (1998) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.289 · Cited by 1,121
Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2
Bohn, L., Lefkowitz, R. J., Gainetdinov, R. R., Peppel, K., Caron, M. G., & Lin, F. (1999) · Science · doi:10.1126/science.286.5449.2495 · Cited by 1,079
Role of β-Arrestin in Mediating Agonist-Promoted G Protein-Coupled Receptor Internalization
Ferguson, S. S. G., Downey, W. E., Colapietro, A.-M., Barak, L. S., Ménard, L., & Caron, M. G. (1996) · Science · doi:10.1126/science.271.5247.363 · Cited by 974
Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas
Parma, J., Duprez, L., SANDE, J. V., Cochaux, P., Gervy, C., Mockel, J., Dumont, J. E., & Vassart, G. (1993) · Nature · doi:10.1038/365649a0 · Cited by 914
Oakley, R. H., Laporte, S. A., Holt, J. A., Caron, M. G., & Barak, L. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910348199 · Cited by 882
DeFea, K., Zalevsky, J., Thoma, M. S., Déry, O., Mullins, R. D., & Bunnett, N. W. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.6.1267 · Cited by 820
β-Arrestin 2: A Receptor-Regulated MAPK Scaffold for the Activation of JNK3
McDonald, P. H., Chow, C.-W., Miller, W. E., Laporte, S. A., Field, M. E., Lin, F., Davis, R. J., & Lefkowitz, R. J. (2000) · Science · doi:10.1126/science.290.5496.1574 · Cited by 818
Flagged first, then by citations
Research works printed but not linked: 1
- Roush, 1999, Mol. Pharmacol., 55, 855
Cited by
Sorted by citations
Items 301–400 of 456
Song, Y. B., Park, C., Jeong, J.-Y., & Huh, W. (2013) · Analytical Biochemistry · doi:10.1016/j.ab.2013.12.017 · Cited by 15
“The stability of the GPCR-b-arrestin complex depends on the presence of a cluster of serine and threonine residues in the C-terminal tail of class B receptors [11] and the persistent ubiquitination of b-arrestin associated with class B receptors [12].”
BackgroundSnyder, J. C., Rochelle, L. K., Barak, L. S., & Caron, M. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084476 · Cited by 16
“Interestingly, a handful of other non-GPCRs have shown to be either substrates of GRKs or able to bind arrestins.”
BackgroundInfluentialβ-Arrestins in the Central Nervous System
Latapy, C., & Beaulieu, J. (2013) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394440-5.00011-5 · Cited by 17
Leiber, D., Burlina, F., Byrne, C., Robin, P., Piesse, C., Gonzalez, L., Leclercq, G., Tanfin, Z., & Jacquot, Y. (2015) · Biochemical Journal · doi:10.1042/bj20150744 · Cited by 15
Behavioral Characterization of β-Arrestin 1 Knockout Mice in Anxiety-Like and Alcohol Behaviors
Robins, M. T., Chiang, T., Berry, J. N., Ko, M. J., Ha, J. E., & van Rijn, R. M. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00054 · Cited by 15
“…GPCR signaling; β-arrestins can uncouple the G-protein from receptors to “arrest” signaling and assist in receptor internalization (Lohse et al., 1990; Oakley et al., 2000, 2001; Laporte et al., 2002; Tian et al., 2014), but interestingly have also been found capable of Abbreviations: CPP,…”
BackgroundLittmann, T., Buschauer, A., & Bernhardt, G. (2019) · Analytical Biochemistry · doi:10.1016/j.ab.2019.02.023 · Cited by 15
The Use of Biosensors to Study GPCR Function: Applications for High-Content Screening
Conway, B. R., & Demarest, K. T. (2002) · Receptors and Channels · doi:10.1080/10606820214641 · Cited by 15
β-Arrestin-Biased Signaling by the β-Adrenergic Receptors
Shenoy, S. K. (2011) · Current topics in membranes · doi:10.1016/b978-0-12-384921-2.00003-3 · Cited by 14
Role of G protein-coupled receptors-microRNA interactions in gastrointestinal pathophysiology
Law, I. K. M., Padua, D. M., Iliopoulos, D., & Pothoulakis, C. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00144.2017 · Cited by 14
“This leads to desensitization of the NTS1 receptor to extracellular NTS (71, 92, 93) and prevents the cells from being overstimulated.”
BackgroundMalik, M., Fang, Y., Wakle‐Prabagaran, M., Roh, M., Prifti, K. K., Frolova, A. I., Imoukhuede, P. I., & England, S. K. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101646 · Cited by 14
“The two known OXTR agonists—TCOT39 and WAY26746—decreased cell surface V281M OXTR, likely due to β-arrestin-induced internalization after OXTR activation (20, 21).”
BackgroundLundell, I., Bernhardt, N. R., Johnsson, A., & Larhammar, D. (2011) · Regulatory Peptides · doi:10.1016/j.regpep.2011.03.004 · Cited by 13
“Although the C-terminal domain of Y2 may not have the optimal combinations of serine or threonine residues for phosphorylation required for arrestin binding [56] this segment is able to mediate a very high level of internalization when inserted into Y1.”
Roy, S. J., Parent, A. V., Gallant, M. A., de Brum-Fernandes, A. J., Staňková, J., & Parent, J. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.12.022 · Cited by 13
Mitselos, A., Berghe, P. V., Peeters, T. L., & Depoortere, I. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.11.004 · Cited by 13
Phosphorylation patterns in the AT1R C-terminal tail specify distinct downstream signaling pathways
Gareri, C., Pfeiffer, C. T., Jiang, X. C., Paulo, J. A., Gygi, S. P., Pham, U., Chundi, A., Wingler, L. M., Staus, D. P., Stępniewski, T. M., et al. (2024) · Science Signaling · doi:10.1126/scisignal.adk5736 · Cited by 11
“Our proteomics data and functional studies of AT1R mutants identified the proximal and middle phosphorylation sites found in previous studies to be critical for β - arrestin and receptor internalization ( 15 , 16 , 20 , 44 – 47 ).”
BackgroundNilssen, L. S., Dajani, O. F., Christoffersen, T., & Sandnes, D. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20260 · Cited by 13
“The different patterns of desensitization may be related to differential trafficking of phosphorylated receptors [Fonseca et al., 1995; Oakley et al., 2001].”
BackgroundTreppiedi, D., Peverelli, E., Giardino, E., Ferrante, E., Calebiro, D., Spada, A., & Mantovani, G. (2016) · Hormone and Metabolic Research · doi:10.1055/s-0042-116025 · Cited by 12
“For class B receptors, β-arrestin remains tightly associated with the receptors and they internalize as a stable unit into early endosomes [59].”
BackgroundMorinelli, T. A., Walker, L. P., Velez, J. C. Q., & Ullian, M. E. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.12.018 · Cited by 12
Boson, W. L., Manna, T. D., Damiani, D., de Miranda, D. M., Gadelha, M. R., Liberman, B., Corrêa, H., Romano‐Silva, M. A., Friedman, E., Silva, F. F., et al. (2006) · Genetic Testing · doi:10.1089/gte.2006.10.157 · Cited by 12
Morinelli, T. A., Kendall, R. T., Luttrell, L. M., Walker, L. P., & Ullian, M. E. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.151829 · Cited by 12
Liu, L., Markus, I., Vandenberg, R. J., Neilan, B. A., Murray, M. T., & Burcher, E. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00051.2004 · Cited by 12
“The mechanism of desensitization in mammalian systems involves agonist-induced phosphorylation of Ser/Thr residues at the COOH terminus by a receptor-specific kinase, allowing -arrestin to bind and cause receptor internalization (23, 26, 39).”
BackgroundTwo serines in the distal C-terminus of the human ß1-adrenoceptor determine ß-arrestin2 recruitment
Hinz, L., Ahles, A., Ruprecht, B., Küster, B., & Engelhardt, S. H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176450 · Cited by 11
Assessment of Receptor Internalization and Recycling
Koenig, J. (2004) · Humana Press eBooks · doi:10.1385/1-59259-754-8:249 · Cited by 11
Lee, S., Howell, B. J., & Kunapuli, P. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(06)14006-9 · Cited by 11
Huang, H., Deng, X., He, X., Yang, W., Li, G., Shi, Y., Shi, L., Mei, L., Gao, J., & Zhou, N. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.04.006 · Cited by 11
Yu, J., Prado, G. N., Taylor, L., Pal‐Ghosh, R., & POLGAR, P. R. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00177-7 · Cited by 11
Emerging involvement of CXCL13 in cancer development and progression
Argyris, D. G., Johnson, L., Hägglöf, T., Filippou, P. S., & Karagiannis, G. S. (2025) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2025.12.005 · Cited by 10
The function of GPCRs in different bone cells
Zhang, Y., Wang, N., Qiu, Z., Wang, J., An, W.-N., Shi, L.-D., Chen, F., Zhang, D., Wang, S., Yang, T., et al. (2025) · International Journal of Biological Sciences · doi:10.7150/ijbs.113585 · Cited by 10
“Traditional views of plasma membrane-restricted GPCR signaling are evolving with discoveries of endosomal persistence [150-152].”
Gαq signalling from endosomes: A new conundrum
Daly, C. A., & Plouffe, B. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16248 · Cited by 11
“The affinity of β -arrestins for GPCRs delineates two major classes of receptors and determines the fate of internalised receptors (Oakley et al., 2001, 2000).”
Guo, L., Zhou, Q., Yu, Y., Chen, L., Shi, Y., Luo, J., Benovic, J., Lü, J., & Zhou, N. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.081307 · Cited by 10
“A previous study has demonstrated that a cluster of serine/threonine residues in the C-terminal tail is essential for receptor internalization and desensitization, serving as targets for agonist-induced phosphorylation and association of the arrestin adaptor proteins (Oakley et al., 2001).”
BackgroundIntracellular Trafficking of Neuropeptide Y Receptors
Mörl, K., & Beck‐Sickinger, A. G. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.02.011 · Cited by 10
β-Arrestin-Mediated Regulation of the Human Ether-a-go-go-Related Gene Potassium Channel
Sangoi, M., Lamothe, S. M., Guo, J. X., Yang, T., Li, W., Avery, E. G., Fisher, J. T., & Zhang, S. (2017) · Molecular Pharmacology · doi:10.1124/mol.116.108035 · Cited by 9
“Upon ligand-binding, G protein-coupled receptor kinases phosphorylate Ser-Thr residues in the cytoplasmic C-terminus of GPCRs to promote β-arrestin recruitment (Reiter and Lefkowitz, 2006; Oakley et al., 2001).”
BackgroundImmobilization of arrestin-3 on different biosensor platforms for evaluating GPCR binding
Avsar, S. Y., Kapinos, L. E., Schoenenberger, C., Schertler, G. F. X., Mühle, J., Meger, B., Lim, R. Y. H., Ostermaier, M. K., Lesca, E., & Palivan, C. G. (2020) · Physical Chemistry Chemical Physics · doi:10.1039/d0cp01464h · Cited by 10
The Oxytocin Product Correlates with Total Oxytocin Received during Labor: A Research Methods Study
Lewis, L. S., Manuck, T. A., Allen, T. K., James, A., Seco, A., Deneux‐Tharaux, C., & Grotegut, C. A. (2017) · American Journal of Perinatology · doi:10.1055/s-0037-1606119 · Cited by 9
Ligand-Specific Signaling Profiles and Resensitization Mechanisms of the Neuromedin U2 Receptor
Alhosaini, K. A., Bahattab, O. S., Qassam, H. S., Challiss, R. A. J., & Willars, G. B. (2018) · Molecular Pharmacology · doi:10.1124/mol.117.111070 · Cited by 9
“Ligands that bind with high affinity are likely to be co-internalized with the receptor (Oakley et al., 2001).”
BackgroundCarraway, R. E., Hassan, S., & Dobner, P. R. (2008) · Regulatory Peptides · doi:10.1016/j.regpep.2008.01.009 · Cited by 9
Schümann, M., Nakagawa, T., Mantey, S. A., Howell, B. W., & Jensen, R. T. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.11.022 · Cited by 9
Effect of GABAA receptor activation on UT-coupled signaling pathways in rat cortical astrocytes
Desrues, L., Lefebvre, T., Diallo, M., Gandolfo, P., Leprince, J., Chatenet, D., Vaudry, H., Tonon, M., & Castel, H. (2008) · Peptides · doi:10.1016/j.peptides.2008.01.024 · Cited by 9
Basal interaction of the orphan receptor GPR101 with arrestins leads to constitutive internalization
Abboud, D., Abboud, C., Inoue, A., Twizere, J., & Hanson, J. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.116013 · Cited by 8
Schuler, B., Rieger, G., Gubser, M., Arras, M., Gianella, M., Vogel, O., Jirkof, P., Cesarovic, N., Klohs, J., Jakob, P., et al. (2014) · Acta Physiologica · doi:10.1111/apha.12244 · Cited by 8
“Of note, there are two types of 7TM G-protein-coupled receptors (GPCRs), those forming stable signalling complexes with b-arrestin (class B receptors) and those able to form only transient signalling complexes (class A receptors; Shenoy & Lefkowitz 2011).”
BackgroundInfluentialNagi, K., Kaur, S., Bai, Y., & Shenoy, S. K. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109759 · Cited by 8
TRANSFLUOR Provides a Universal Cell-Based Assay for Screening G-Protein-Coupled Receptors
Oakley, R. H., Cowan, C. L., Hudson, C. C., & Loomis, C. R. (2006) · CRC Press eBooks · doi:10.1201/9781420015706-36 · Cited by 8
GB83, an Agonist of PAR2 with a Unique Mechanism of Action Distinct from Trypsin and PAR2-AP
Heo, Y., Yang, E., Lee, Y., Seo, Y., Ryu, K., Jeon, H., & Namkung, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810631 · Cited by 7
“β-Arrestin is a key component linking GPCRs to the endocytic machinery, and the stability of the GPCR/β-arrestin complex determines the trafficking of receptors that are rapidly redistributed to the plasma membrane or degraded and slowly recovered [35,36].”
BackgroundTeixeira, L. B., Blouin, M., Gouill, C. L., Picard, L.-P., Costa-Neto, C. M., Bouvier, M., & Parreiras‐e‐Silva, L. T. (2025) · Science Signaling · doi:10.1126/scisignal.adf6206 · Cited by 7
Arrestin recognizes GPCRs independently of the receptor state
Petrovic, I. M., Tatlı, M., Desai, S., Grahl, A., Ni, D., Stahlberg, H., Spang, A., Grzesiek, S., & Abiko, L. A. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2501487122 · Cited by 7
Robust GRK2/3/6-dependent desensitization of oxytocin receptor in neurons
George, K., Hoang, H., Tibbs, T., Nagaraja, R. Y., Li, G., Troyano‐Rodriguez, E., & Ahmad, M. (2024) · iScience · doi:10.1016/j.isci.2024.110047 · Cited by 7
“30,31 In uterine myometrial cells, knocking down GRK6, but not GRK2, impaired OXTR desensitization, 32 thus highlighting cell-specific differences.”
InfluentialOzawa, K., Hudson, C. C., Wille, K. R., Karaki, S., & Oakley, R. H. (2005) · Cytometry Part A · doi:10.1002/cyto.a.20128 · Cited by 7
Nigawara, T., HORIBA, N., TOZAWA, F., Kasagi, Y., Uchida, K., Iwasaki, Y., & Suda, T. (2003) · Pituitary · doi:10.1023/b:pitu.0000004796.71734.e4 · Cited by 7
“The mechanism of membrane receptor trafficking has been extensively explored in β-adrenergic receptor [28].”
BackgroundLigand-Supported Purification of the Urotensin-II Receptor
Du, A. T. N., Onan, D., Dinh, D., Lew, M. J., Ziogas, J., Aguilar, M., Pattenden, L. K., & Thomas, W. G. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.065151 · Cited by 7
“These signals are terminated by receptor phosphorylation mediated by GPCR kinases and recruitment of arrestins, preventing further interaction with G proteins and promoting receptor internalization (Oakley et al., 2001).”
BackgroundReceptor Determinants for β-Arrestin Functional Specificity at C-X-C Chemokine Receptor 5
Crecelius, J. M., Manz, A. R., Benzow, S., & Marchese, A. (2024) · Molecular Pharmacology · doi:10.1124/molpharm.124.000942 · Cited by 6
Danoff, J. S., Page, E. A., Perkeybile, A. M., Kenkel, W. M., Yee, J. R., Ferris, C. F., Carter, C. S., & Connelly, J. J. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1225197 · Cited by 6
Roy, S., Curry, S. D., Bibbey, M. G., Chapnick, D. A., Liu, X., Goodwin, A. P., & Cha, J. N. (2021) · Biotechnology and Bioengineering · doi:10.1002/bit.27964 · Cited by 6
“Cell surface receptor targeting with antibodies or other high‐affinity ligands has been explored for applications ranging from drug delivery, (Oakley et al., 2001) fluorophore conjugation (Sridharan et al.”
BackgroundQi, A., Houston‐Cohen, D., Naruszewicz, I., Harden, T. K., & Nicholas, R. A. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01135.x · Cited by 6
“…terminus of several GPCRs, including the P2Y4 receptor, were shown to be important for agonist-induced internalization (Brinson and Harden, 2001; Oakley et al., 2001), we generated a double mutant receptor, P2Y1-S352A/S354A, and measured the rate and extent of agonist-induced loss of surface…”
BackgroundAlmeida, T. A., Rodriguez, Y., Hernández, M., Reyes, R., & Bello, A. R. (2009) · Peptides · doi:10.1016/j.peptides.2009.12.007 · Cited by 6
“3) and are involved in the regulation of receptor desensitization, sequestration, and resensitization [6,11].”
Down-regulation of Cyclooxygenase-2 by the Carboxyl Tail of the Angiotensin II Type 1 Receptor
Sood, R., Minzel, W., Rimon, G., Tal, S., & Barki‐Harrington, L. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.587576 · Cited by 6
“Immediately thereafter, the receptor is phosphorylated by G protein-coupled receptor kinases (GRKs) on distinct serine/threonine site located on its carboxyl terminus (14), thereby initiating a second wave of arrestin-dependent signaling (6).”
BackgroundCXCR2 Inverse Agonism Detected by Arrestin Redistribution
Kredel, S., Wolff, M., Wiedenmann, J., Moepps, B., Nienhaus, G. U., Gierschik, P., Kistler, B., & Heilker, R. (2009) · SLAS DISCOVERY · doi:10.1177/1087057109344616 · Cited by 6
Deubiquitinases and Their Emerging Roles in β-Arrestin-Mediated Signaling
Shenoy, S. K. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-397925-4.00020-1 · Cited by 6
Canonical and Noncanonical Signaling Roles of β-Arrestins in Inflammation and Immunity
Ahmadzai, M. M., Broadbent, D. G., Occhiuto, C. J., Yang, C., Das, R., & Subramanian, H. (2017) · Advances in immunology · doi:10.1016/bs.ai.2017.05.004 · Cited by 6
Dissecting the structural features of β-arrestins as multifunctional proteins
Yun, Y., Ji, J., & Lee, H. H. (2021) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2021.140603 · Cited by 5
High Content Screening to Monitor G Protein-Coupled Receptor Internalisation
Heilker, R. (2007) · Ernst Schering Research Foundation workshop/Ernst Schering Foundation Symposium proceedings · doi:10.1007/2789_2006_011 · Cited by 6
“for the β2 adrenergic receptor, the ArrGFP is released after the formation of clathrin-coated pits ( Oakley et al. 2000, 2001 ).”
BackgroundBrouillette, R. L., Mona, C. E., Desgagné, M., Hassanzedeh, M., Breault, É., Lussier, F., Belleville, K., Longpré, J., Grandbois, M., Boudreault, P., et al. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107597 · Cited by 5
Mécanismes moléculaires de la tolérance aux opiacés et aux cannabinoïdes
Marie, N. (2009) · Réanimation · doi:10.1016/j.reaurg.2009.06.016 · Cited by 5
Triphenylmethane Dye Activation of Beta-Arrestin
Barak, L. S., Bai, Y., Snyder, J. C., Wang, J., Chen, W., & Caron, M. G. (2013) · Biochemistry · doi:10.1021/bi400217r · Cited by 5
Neuschäfer‐Rube, F., Hermosilla, R., Kuna, M., Pathe‐Neuschäfer‐Rube, A., Schülein, R., & Püschel, G. P. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706282 · Cited by 5
“Clusters of Ser/Thr residues in the C- terminal domain of many GPCR were shown to be important determinants for receptor desensitization, acting as targets for agonist-induced receptor phosphorylation and/or as binding sites for the adaptor protein b-arrestin (Oakley et al., 2001).”
BackgroundThe endosomal–lysosomal system
Maxfield, F. R., & Mukherjee, S. (2004) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198508786.003.0001 · Cited by 6
Kim, K., Ji, J. S., Kim, H. R., Choi, Y., Lee, H. H., Inoue, A., & Chung, K. Y. (2025) · Communications Biology · doi:10.1038/s42003-025-08649-w · Cited by 5
Tóth, A. D., Soltész‐Katona, E., Kis, K., Guti, V., Gilzer, S., Prokop, S., Boros, R., Misák, Á., Balla, A., Várnai, P., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114241 · Cited by 4
Desensitization and internalization mechanisms of the 5‐HT4 receptors
Mnie‐Filali, O., & Piñeyro, G. (2012) · Wiley Interdisciplinary Reviews Membrane Transport and Signalling · doi:10.1002/wmts.52 · Cited by 4
Sato, M., Aoki, H., Nakamura, T., Onodera, S., Yamaguchi, A., Saitô, A., & Azuma, T. (2020) · Journal of Periodontal Research · doi:10.1111/jre.12762 · Cited by 4
Fluoroalkoxylated C-3 and C-9 (S)-12-bromostepholidine analogues with D1R antagonist activity
Namballa, H. K., Decker, A. M., Dorogan, M., Gudipally, A. R., Goclon, J., & Harding, W. W. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106862 · Cited by 4
Thomsen, W. J., & Behan, D. P. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00062-6 · Cited by 4
Luttrell, L. M. (2005) · Contemporary clinical neuroscience · doi:10.1007/978-1-59259-919-6_8 · Cited by 4
Single-molecule analysis of receptor-β-arrestin interactions in living cellsPreprint
Grimes, J., Kőszegi, Z., Lanoiselée, Y., Miljuš, T., O’Brien, S. L., Stępniewski, T. M., Medel-Lacruz, B., Baidya, M., Makarova, M., Owen, D. M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.15.516577 · Cited by 4
“…complexes were widely assumed to be sufficiently stable to allow receptors and β-arrestins to reach CCPs together, as in the case of Class A GPCRs, or even co-internalize and remain associated in endosomes, as in the case of Class B receptors (Oakley et al., 1999, 2001; Oakley et al., 2000).”
BackgroundLanoie, A., Ferková, S., Caron-Duval, É., Dallagnol, J. C. C., Diarra, S., Murza, A., Tremblay, A., Théroux, L., Breault, É., Ranjbaran, A., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118664 · Cited by 3
Senćanski, M., Glišić, S., Kubale, V., Cotman, M., Mavri, J., & Vrecl, M. (2024) · Biomolecules · doi:10.3390/biom14040423 · Cited by 3
Posttranslational Control of Protein Trafficking in the Post-Golgi Secretory and Endocytic Pathway
Piper, R. C., & Bryant, N. J. (2009) · Springer eBooks · doi:10.1007/978-0-387-93877-6_17 · Cited by 3
Inherited Disorders of Water Handling
Knoers, N. V. A. M., Levtchenko, E. N., & Bichet, D. G. (2022) · Springer eBooks · doi:10.1007/978-3-030-52719-8_112 · Cited by 3
Laferrière, A., & Moss, I. R. (2004) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2004.07.013 · Cited by 3
Arrestin-Dependent ERK Activation and Its Disruption
Luttrell, L. M., & Spiller, B. W. (2017) · Springer eBooks · doi:10.1007/978-3-319-57553-7_15 · Cited by 3
The repertoire of family A-peptide GPCRs in archaic hominins
Mata, X., Renaud, G., & Mollereau, C. (2019) · Peptides · doi:10.1016/j.peptides.2019.170154 · Cited by 3
Structural Diversity and Dynamics of Metabotropic Glutamate Receptor/Beta-Arrestin CouplingPreprint
Marx, D. C., Huynh, K. W., Gonzalez-Hernandez, A. J., Strauss, A., Rico, C. A., Siepe, D. H., Gallo, P. N., Lee, J., Moshtaghin, S. S., Arefin, A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.03.636340 · Cited by 3
Janetzko, J., Deutsch, J. C., Shi, Y., Siepe, D. H., Masureel, M., Liu, W., Viner, R., Inoue, A., Chu, S., Kobilka, B. K., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.06.658200 · Cited by 3
“However, given the range of measured phosphopeptide affinities, it is likely that most class A typology (weakly βarr-interacting) GPCRs 25,37,63,64 would lack suitable C-terminal phosphorylation to effectively capture βarr1 during brief, active-state fluctuations amid excursions to the plasma…”
Mahmoodkhani, M., Amini, M., Derafshpour, L., Ghasemi, M., & Mehranfard, N. (2020) · Experimental Brain Research · doi:10.1007/s00221-020-05937-1 · Cited by 2
Is oxytocin receptor signaling really dispensable for social attachment?
Danoff, J. S., Whelan, E. A., & Connelly, J. J. (2023) · Comprehensive Psychoneuroendocrinology · doi:10.1016/j.cpnec.2023.100178 · Cited by 2
“Ligand-bound OXTR can be internalized in a β-Arrestin dependent manner via interactions between the C terminus of OXTR and β-Arrestin [14].”
BackgroundGPCRs and β-arrestins — an on-off relationship
Thomsen, A. R. B. (2023) · Cell Research · doi:10.1038/s41422-023-00838-8 · Cited by 3
Li, Y., Kawamura, G., Dong, Q., Li, Q., & Ozawa, T. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.4c06986 · Cited by 2
Distinct Phosphorylation Patterns of AT1R by Biased Ligands and GRK Subtypes
Zhang, Z., Liu, C., Gong, J., Su, C., Liu, Z., Li, J., & Zhang, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167988 · Cited by 2
“The phosphorylation pattern on the receptor’s tail influences β -arrestin binding and can induce distinct receptor conformations, thereby shaping downstream signaling outcomes [10–13].”
Walh, R. U. R. (2007) · PubMed · Cited by 2
Overview of Arrestin Mediated Signaling with Receptors and Non-receptor Binding Partners
Zhuo, Y., & Klug, C. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-57553-7_2 · Cited by 2
Garcia-Rojas, E. Y. L., Reyes‐Alcaraz, A., Ruan, K.-H., McConnell, B. K., & Bond, R. A. (2022) · FASEB BioAdvances · doi:10.1096/fba.2022-00038 · Cited by 1
Davenport, A. P., & Daly, C. J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00685.x · Cited by 2
He, X., Yan, L., Wu, Q., Zhang, G., & Zhou, N. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118690 · Cited by 1
Arrestin-mediated trafficking and compartmentalized biology of GPCRs
Thomsen, A. R. B., Hahn, H., & Bunnett, N. W. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85756-7.00004-2 · Cited by 1
Reiter, É. (2021) · Biologie Aujourd hui · doi:10.1051/jbio/2021010 · Cited by 1
“Laprésenceoul ’ absencedeclustersdesérineet de thréonine dans l ’ extrémité C-terminale du RCPG conditionne l ’ af fi nité du recrutement de la b -arrestine et affecte ainsi le tra fi c intracellulaire d ’ un grand nombre de RCPG (Oakley et al. , 2000, 2001).”
BackgroundThe clinical implication of β-arrestins-mediated signaling in memory and cognition
Aghdam, M. M., Mohebalizadeh, M., Sameei, P., & Majidinia, M. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05323-x · Cited by 2
“Understanding the precise mechanisms and the structural basis of these interactions continues to be a critical area of research, providing insights into developing therapeutic agents targeting β-arrestin-biased pathways for various diseases [29–32].”
Brouillette, R. L., Lussier, F., Breault, É., Meneboo, N., Hassanzadeh, M., Tremblay, V., Chartier, M., Midavaine, É., Ulrich, L., Côté, J., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.12.043 · Cited by 1
Factors modulating the assembly of human β2-adrenergic receptor–β-arrestin complexes
Wilhelm, F. M., Pluháčková, K., Janetzko, J., Masureel, M., Marsh, E., Hudspeth, J. D., Gassner, W., Schertler, G. F. X., Kobilka, B. K., & Müller, D. J. (2026) · Nature Structural & Molecular Biology · doi:10.1038/s41594-026-01842-3 · Cited by 1
“For class A GPCRs, such as the β 2 -adrenergic receptor (β 2 AR), which engage β-arrestins only transiently 4,39,40 , phosphoinositides, notably phosphatidylinositol 4,5-bisphosphate (PIP 2 ), are required for β-arrestin recruitment, desensitization and internalization 21,34 .”
Configurational diversity of metabotropic glutamate receptor complexes with beta-arrestins
Marx, D. C., Huynh, K., Gonzalez-Hernandez, A. J., Strauss, A., Rico, C., Siepe, D., Gallo, P. N., Lee, J., Moshtaghin, S. S., Arefin, A., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-77555-4 · Cited by 5
GPCRs and G Protein Activation
Waelbroeck, M. (2012) · InTech eBooks · doi:10.5772/33468 · Cited by 1
Role of β-Arrestins in Endosomal Sorting of G Protein-Coupled Receptors
Malik, R., & Marchese, A. (2012) · InTech eBooks · doi:10.5772/34739 · Cited by 1
“…of -Arrestins in Endosomal Sorting of G Protein-Coupled Receptors 257 Once -arrestins bind and desensitization and receptor internalization have initiated, the two proteins disassociate while the receptor internalizes onto endosomes (Oakley et al., 1999; Oakley et al., 2001; Oakley et al., 2000).”
BackgroundInfluentialHow Arrestin Recognizes and Binds Active GPCRs
Sommer, M. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-57553-7_8 · Cited by 1
Metadata
- Authors
- Oakley, R. H., Laporte, S. A., Holt, J. A., Barak, L. S., & Caron, M. G.
- Affiliations
- Howard Hughes Medical Institute (US)
- Corresponding author
- Caron, Marc G.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-06
- Volume
- 276
- Issue
- 22
- Pages
- 19452-19460
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2083334427
- Cited by
- 455
- References
- 45
- Citations by year
- 2026: 7 · 2025: 19 · 2024: 8 · 2023: 15 · 2022: 14 · 2021: 13 · 2020: 16 · 2019: 10 · 2018: 11 · 2017: 23 · 2016: 9 · 2015: 9 · 2014: 18 · 2013: 17 · 2012: 19
- FWCI
- 10.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl061365-04)
- National Heart, Lung, and Blood Institute (HL61365)
- National Institute of Neurological Disorders and Stroke (NS-19576, R01NS019576)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- beta-arrestin, G protein-coupled receptors, receptor internalization, receptor desensitization, receptor resensitization, serine/threonine phosphorylation, carboxyl-terminal tail, beta2-adrenergic receptor, oxytocin receptor, angiotensin II type 1a receptor, neurokinin-1 receptor, endocytic vesicles
- MeSH terms
- beta-Arrestins, beta-Arrestin 2, Amino Acid Sequence, Cell Line, Cell Membrane, Endocytosis, Humans, Luminescent Proteins, Microscopy, Fluorescence, Molecular Sequence Data, Mutation, Phosphorylation, Plasmids, Protein Binding, Receptors, Angiotensin, Receptors, Cell Surface, Recombinant Fusion Proteins, Time Factors, Transfection, Mutagenesis, Site-Directed, Sequence Homology, Amino Acid, Protein Structure, Tertiary, Receptors, Neurotensin, Receptors, Neurokinin-1, Receptors, Oxytocin, Microscopy, Confocal, Arrestins, Receptor, Angiotensin, Type 1, Green Fluorescent Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review